measuregroup/AID162108

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103194439_AID162108_PMID12657271_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103194824_AID162108_PMID12657271_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103194841_AID162108_PMID12657271_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103194875_AID162108_PMID12657271_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103195621_AID162108_PMID12657271_VALUE5
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06401
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Inhibition of [3H]P4 to progesterone receptor (PR) of human T47D breast carcinoma cells
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103194841 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103194875 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103194439 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103195621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103194824
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID162108

Total number of triples: 15.